Clinical Trial Update: Study of Picoplatin Efficacy After Relapse [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the efficacy of picoplatin after relapse in small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Picoplatin (picoplatin)

Snippet

Sponsor: Poniard Pharmaceuticals | Conditions: Small Cell Lung Cancer | Phase 3 | Status: UNKNOWN